Researchers claim that a blood sample, or liquid biopsy, can reveal which patients will respond to checkpoint inhibitor-based immunotherapies.
Direct to consumer testing can potentially be quite dangerous without appropriate regulations and support to fully understand the implications of the information a consumer receives.
A French start-up has urged the development of more powerful drugs to combat antibiotic-resistant diseases, with its new drug, Eligobiotics.
A genetic fault has been identified in people with an aggressive type of leukemia that can significantly affect how they respond to treatment.
A high-speed method has been developed that produces small proteins for custom-designed therapeutics, that may have applications in fighting disease agents.
Scientists have used a genetic engineering technique in a three-generation family with Tourette syndrome, to determine what causes the disease.
Using a computational technique that accounts for how genes interact, scientists revealed genes that may be related to autism spectrum disorder.
A gene variant, associated with Alzheimer’s has been discovered that speeds up brain inflammation and kills brain cells, furthering tau tangles.
Researchers have added a scaffold/matrix attatchment region (S/MAR) to a conventional adeno-associated virus (AVV) vector used for gene transfer.
New research has revealed that fathers pass on four times as many new genetic mutations as mother, making them a driver for rare childhood diseases.
UK scientists have edited the DNA of human embryos for the first time, helping them further understand infertility and miscarriage.